Verisante Technology Launches Innovative Skin Cancer Detection Device
Study data collected from tests on 1,000 skin lesions shows higher success rate than competitors’ devices. We’re pleased to announce the release of another Smallcaps.us interview, this time taking a closer look at an up and coming company in the medical devices domain. Verisante Technology Inc. (VRS – $0.63) develops cancer detection devices and has been generating buzz among investors […]
Read more